GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (STU:NTK1) » Definitions » Price-to-Owner-Earnings

NetScientific (STU:NTK1) Price-to-Owner-Earnings : (As of Apr. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is NetScientific Price-to-Owner-Earnings?

As of today (2024-04-29), NetScientific's share price is €0.68. NetScientific does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for NetScientific's Price-to-Owner-Earnings or its related term are showing as below:


STU:NTK1's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 32.12
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-29), NetScientific's share price is €0.68. NetScientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.15. Therefore, NetScientific's PE Ratio for today is At Loss.

As of today (2024-04-29), NetScientific's share price is €0.68. NetScientific's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.19. Therefore, NetScientific's PE Ratio without NRI for today is At Loss.


NetScientific Price-to-Owner-Earnings Historical Data

The historical data trend for NetScientific's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetScientific Price-to-Owner-Earnings Chart

NetScientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NetScientific Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NetScientific's Price-to-Owner-Earnings

For the Biotechnology subindustry, NetScientific's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NetScientific's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NetScientific's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where NetScientific's Price-to-Owner-Earnings falls into.



NetScientific Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

NetScientific's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.68/-0.07
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NetScientific  (STU:NTK1) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


NetScientific Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of NetScientific's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


NetScientific (STU:NTK1) Business Description

Traded in Other Exchanges
Address
20 Saint Andrew Street, Holborn Circus, London, GBR, EC4A 3AG
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

NetScientific (STU:NTK1) Headlines

No Headlines